✦ LIBER ✦

OP23.03: First trimester combined screening with PLGF, free β-HCG and PAPP-A

✍ Scribed by K. O. Kagan; M. Hoopmann; H. Abele; B. Yazdi; K. Lüthgens

Book ID: 115562995
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 52 KB
Volume: 40
Category: Article
ISSN: 0960-7692
DOI: 10.1002/uog.11608

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-trimester screening with free β-hC

First-trimester screening with free β-hCG, PAPP-A, and nuchal translucency in pregnancies conceived by in vitro fertilization

✍ Sriram C. Perni; Mladen Predanic; Alexander Friedman; Claudel Jean-Pierre; Robin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 77 KB

P06.13: Effect of gestation on β-hCG and

P06.13: Effect of gestation on β-hCG and PAPP-A in the first-trimester combined screening

✍ C. Hsiao 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

First trimester screening for Down's syn

First trimester screening for Down's syndrome using maternal serum PAPP-A and free β=hCG in combination with fetal nuchal translucency thickness

✍ Roberto Biagiotti; Laura Brizn; Enrico Periti; Albertino D'Agata; Ermanno VanZi; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

OP23.01: A prospective study evaluating

OP23.01: A prospective study evaluating the performance of first trimester combined screening for trisomy 21 using repeated sampling of the maternal serum markers PAPP-A and free β-hCG

✍ C. K. Ekelund; D. Wright; S. Ball; I. Kirkegaard; P. Noergaard; F. S. Joergensen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Screening for trisomy 21 in twin pregnan

Screening for trisomy 21 in twin pregnancies in the first trimester using free β-hCG and PAPP-A, combined with fetal nuchal translucency thickness

✍ Kevin Spencer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

In the ®rst trimester of pregnancy the biochemical markers free b-hCG and pregnancy associated plasma protein-A (PAPP-A) are used for the prenatal screening of trisomy 21, either alone or in combination with nuchal translucency (NT) thickness. In this study, I have analysed the distribution of these

FIRST-TRIMESTER BIOCHEMICAL SCREENING FO

FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROME WITH THE USE OF PAPP-A, AFP, AND β-hCG

✍ E. CASALS; A. FORTUNY; J. G. GRUDZINSKAS; Y. SUZUKI; B. TEISNER; C. COMAS; C. SA 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

Biochemical screening for Down syndrome (DS) is well established in the second trimester of pregnancy, but there is little information available on its value in the first trimester. This study describes our preliminary results with biochemical screening for DS in the first trimester of pregnancy in